Skip to main content

Breast Cancer Clinical Trials

Review the breast cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 451-475 of 919

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of BND-35 in Participants With Advanced Solid Tumors
Status: Active
Location: University of Colorado, Denver, Colorado
Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology
Status: Active
Location: See ClinicalTrials.gov
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
Status: Active
Location: See ClinicalTrials.gov
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Status: Active
Location: See ClinicalTrials.gov
Time Restricted Eating During Chemotherapy for Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.
Status: Active
Location: See ClinicalTrials.gov
Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy
Status: Enrolling by Invitation
Location: 2 locations
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Status: Enrolling by Invitation
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Status: Enrolling by Invitation
Location: 3 locations
Combination Study of SV-BR-1-GM With Retifanlimab
Status: Enrolling by Invitation
Location: See ClinicalTrials.gov
Non-surgical Approach (Radiation Therapy) for the Treatment of Early Stage Breast Cancer Patients with an Exceptional Response to Neoadjuvant Chemotherapy, NoCUT-BC Trial
Status: Approved
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A New Molecular Biomarker Test for Adapting Neoadjuvant Treatment in Patients with HER2-Positive Early-Stage Breast Cancer, EUREKA Trial
Status: Approved
Location: 9 locations
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients with Minimal Residual Disease, MIRI Trial
Status: Approved
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Taletrectinib for the Treatment of Patients with CDH1-Mutated, Metastatic Invasive Lobular Breast Cancer, TaCe-1 Trial
Status: Approved
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
Status: Approved
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Pulsed Electric Field Ablation for the Treatment of Metastatic Soft Tissue Lesions in Patients with Breast Cancer
Status: Approved
Location: University of California San Francisco, San Francisco, California
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Status: Temporarily Closed to Accrual
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial
Status: Temporarily Closed to Accrual
Location: 704 locations
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in Patients with Breast Cancer
Status: Temporarily Closed to Accrual
Location: 4 locations
Pembrolizumab in Treating Patients with Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas